Ototoxicity may be associated with protease inhibitor therapy.
Williams
B
B
D000328:Adult; D001304:Auditory Diseases, Central / Q000139:chemically induced*; D003638:Deafness / Q000139:chemically induced; D006801:Humans; D061466:Lopinavir; D008297:Male; D008928:Mitochondria / Q000187:drug effects; D011744:Pyrimidinones / Q000009:adverse effects; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D019438:Ritonavir / Q000009:adverse effects
D011744:Pyrimidinones; D018894:Reverse Transcriptase Inhibitors; D061466:Lopinavir; D019438:Ritonavir